Skip to main content

The Estée Lauder Companies Target of Unusually High Options Trading (NYSE:EL)

Tuesday, May 4, 2021 | MarketBeat

The Estée Lauder Companies Inc. (NYSE:EL) was the recipient of unusually large options trading on Monday. Stock traders bought 4,293 put options on the stock. This is an increase of 1,758% compared to the average daily volume of 231 put options.

In other The Estée Lauder Companies news, CFO Tracey Thomas Travis sold 22,924 shares of the stock in a transaction that occurred on Friday, April 9th. The shares were sold at an average price of $300.01, for a total value of $6,877,429.24. Following the transaction, the chief financial officer now directly owns 54,263 shares in the company, valued at $16,279,442.63. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, major shareholder Lal Family Partners Lp sold 2,000,000 shares of the stock in a transaction that occurred on Monday, March 8th. The shares were sold at an average price of $282.19, for a total transaction of $564,380,000.00. Insiders have sold a total of 2,149,073 shares of company stock valued at $608,055,929 over the last three months. 13.95% of the stock is currently owned by insiders.

Institutional investors have recently added to or reduced their stakes in the business. Old North State Trust LLC lifted its holdings in The Estée Lauder Companies by 280.7% in the fourth quarter. Old North State Trust LLC now owns 712 shares of the company's stock valued at $190,000 after acquiring an additional 525 shares during the period. UMB Bank N A MO raised its stake in shares of The Estée Lauder Companies by 599.0% during the 1st quarter. UMB Bank N A MO now owns 23,488 shares of the company's stock worth $6,832,000 after buying an additional 20,128 shares during the last quarter. LGT Capital Partners LTD. raised its stake in shares of The Estée Lauder Companies by 5.4% during the 4th quarter. LGT Capital Partners LTD. now owns 624,288 shares of the company's stock worth $166,179,000 after buying an additional 32,099 shares during the last quarter. Argent Trust Co raised its stake in shares of The Estée Lauder Companies by 6.7% during the 4th quarter. Argent Trust Co now owns 11,398 shares of the company's stock worth $3,034,000 after buying an additional 719 shares during the last quarter. Finally, Robbins Farley LLC acquired a new position in shares of The Estée Lauder Companies during the 4th quarter worth $2,375,000. 54.98% of the stock is owned by institutional investors.

NYSE:EL opened at $288.93 on Tuesday. The firm's fifty day moving average price is $299.85 and its 200 day moving average price is $267.20. The Estée Lauder Companies has a 1-year low of $158.25 and a 1-year high of $318.34. The company has a debt-to-equity ratio of 1.10, a current ratio of 1.85 and a quick ratio of 1.39. The firm has a market cap of $104.81 billion, a price-to-earnings ratio of 176.18, a price-to-earnings-growth ratio of 3.76 and a beta of 0.87.

The Estée Lauder Companies (NYSE:EL) last posted its quarterly earnings data on Monday, May 3rd. The company reported $1.62 earnings per share for the quarter, beating analysts' consensus estimates of $1.32 by $0.30. The Estée Lauder Companies had a net margin of 4.38% and a return on equity of 32.72%. The firm had revenue of $3.86 billion for the quarter, compared to analyst estimates of $3.90 billion. During the same period last year, the firm posted $0.85 EPS. The Estée Lauder Companies's quarterly revenue was up 15.5% on a year-over-year basis. As a group, analysts expect that The Estée Lauder Companies will post 5.24 earnings per share for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, June 15th. Shareholders of record on Friday, May 28th will be issued a $0.53 dividend. This represents a $2.12 dividend on an annualized basis and a yield of 0.73%. The Estée Lauder Companies's dividend payout ratio (DPR) is currently 51.46%.

Several equities analysts have commented on EL shares. Credit Suisse Group increased their price target on shares of The Estée Lauder Companies from $254.00 to $305.00 and gave the company an "outperform" rating in a research note on Monday, February 8th. DA Davidson increased their price target on shares of The Estée Lauder Companies from $320.00 to $348.00 and gave the company a "buy" rating in a research note on Tuesday, March 2nd. Argus increased their price target on shares of The Estée Lauder Companies from $320.00 to $340.00 and gave the company a "buy" rating in a research note on Tuesday, April 13th. Jefferies Financial Group upgraded shares of The Estée Lauder Companies from a "hold" rating to a "buy" rating and increased their price target for the company from $240.00 to $310.00 in a research note on Monday, February 8th. Finally, Wells Fargo & Company upgraded shares of The Estée Lauder Companies from an "equal weight" rating to an "overweight" rating and raised their target price for the stock from $290.00 to $340.00 in a research report on Tuesday, March 30th. Five equities research analysts have rated the stock with a hold rating and sixteen have given a buy rating to the stock. The company presently has an average rating of "Buy" and a consensus target price of $297.78.

About The Estée Lauder Companies

The Estée Lauder Companies Inc manufactures and markets skin care, makeup, fragrance, and hair care products. The company offers a range of skin care products, including moisturizers, serums, cleansers, toners, body care, exfoliators, acne care and oil correctors, facial masks, cleansing devices, and sun care products; and makeup products, such as lipsticks, lip glosses, mascaras, foundations, eyeshadows, nail polishes, and powders, as well as compacts, brushes, and other makeup tools.

Further Reading: What is a CD ladder?

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected]

Featured Article: What is a Swap?


7 Healthcare Stocks Delivering Innovation in 2021

We all knew that traditional healthcare services were disrupted in 2020. The patient-doctor relationship went virtual. In the early months of the pandemic, many people in need of elective surgeries simply did not have that option available to them. And even local pharmacies took on a new e-commerce role as curbside pickup or home delivery of prescription medication became the norm.

Not surprisingly healthcare stocks were battered last year. Overall, the sector was down 11%, far below the S&P 500 Index that climbed over 15%.

However, the market is always forward-looking with a particular eye towards innovation. The healthcare sector has many companies that are developing innovative approaches in areas such as gene editing. And other companies are in late-stage trials for drugs that can deliver breakthrough results for conditions that continue to plague our world.

That’s the focus of this presentation. We’ve identified 7 healthcare stocks that are delivering innovative ideas that will help deliver better patient outcomes. And in some cases will revolutionize medicine altogether. These are also the stocks that analysts have their eye on.

View the "7 Healthcare Stocks Delivering Innovation in 2021".


MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.